Ledipasvir+Sofosbuvir and Sofosbuvir+Velpatasvir for Pts With Indolent Bcell Lymphoma Associated With HCV Infection

NCT02836925 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Indolent B-cell Lymphoma
Hepatitis C

Interventions

DRUG: Ledipasvir+Sofosbuvir
DRUG: Sofosbuvir+Velpatasvir

Sponsor

Fondazione Italiana Linfomi - ETS